OUH STUDIES

Studies currently being run within Oxford University Hospitals NHS Foundation Trust.

Showing 181 - 190 of 700 studies

Neurological

A Registry of Patient treated with Fintepla (Tapestry)

This is a post authorization safety study of patients treated with fenfluramine hydrochloride oral solution, conducted at centers prescribing fenfluramine in routine practice. This study will involve neuro-pediatrician's, pediatricians, or neurologists – with experience in the treatment of epilepsy in both European (Germany, Austria, Denmark, Italy, UK, Spain and France) and non-European countries (potentially including US and Japan). The study will last for 10years for first patient first visit with enrollment period spanning over 3years from registry start date. The maximum ...

GO TO STUDY Go

Infection Inflammatory and immune system Metabolic and Endocrine Respiratory

A clinical study comparing the immune response to revaccination with intradermal BCG and aerosol BCG in previously BCG vaccinated healthy adult volunteers with and without Type 2 Diabetes (TB046)

This is a phase 1 study exploring differences between the immunological responses to revaccination with intradermal-BCG and aerosol-inhaled BCG in healthy adults and those with pre-existing T2DM. There will be three study groups with twelve volunteers in each group (Table 2). Volunteers will be enrolled into groups based upon whether they have a diagnosis of T2DM. They will then be vaccinated with intradermal BCG (Groups A and C) or aerosolised BCG (Group B). Objectives: Co-Primary: To compare the immunological response of BCG ...

GO TO STUDY Go

Eye

Real-World, long-term data collection to gain clinical insights into Roche ophthalmology products (VOYAGER STUDY) (VOYAGER)

This study will explore long-term effectiveness, safety, clinical insights, treatment patterns, and factors driving the treatment decisions among patients being treated with specified Roche ophthalmology products approved in retinal indications in real-world, routine clinical practice.

GO TO STUDY Go

Generic health relevance

CompreHensive GeriAtRician led MEdication Review (CHARMER) - Work Package 4 Definitive Trial

As we get older, our bodies are less able to handle some medicines. Medicines that were once effective and safe may not have as much benefit and may have an increased chance of causing harm. Research shows that almost half of older people in hospital are prescribed a medication with a risk of harm, but these medicines are rarely stopped. In our previous research we asked older people and their carers about their thoughts on stopping these medicines. They told ...

GO TO STUDY Go

Cardiovascular Metabolic and Endocrine

Exploring Intramyocellular Magnesium Augmentation: Implications for Myocardial and Skeletal Muscle Metabolism in Individuals with Heart Failure with Preserved Ejection Fraction

In patients with heart failure, serum hypomagnesaemia is common and attributed to increased renal magnesium (Mg2+) secretion and diuretic therapy. Serum hypomagnesemia is associated with increased heart failure presentations and hospitalisations in patients with heart failure with preserved ejection fraction (HFpEF). There is a poor correlation between serum Mg2+ (the compartment which can be measured) and intracellular Mg2+ concentrations9 (the compartment in which Mg2+ regulates cellular processes) with serum Mg2+ being a poor surrogate for total body Mg2+ content. Using ...

GO TO STUDY Go

Reproductive health and childbirth

Baby-CINO: CaffeINe treatment Optimisation in premature infants

Babies born prematurely can frequently experience periods where they stop breathing, known as apnoea. These events can be life threatening and may have long term effects on brain development, so it is essential to reduce the likelihood of occurrence. Caffeine citrate is given to babies born very prematurely as it can reduce apnoea. This treatment is usually given at a similar dose for all babies and is stopped when they reach approximately 34 weeks postmenstrual age. However, some babies experience ...

GO TO STUDY Go

Cancer and neoplasms

Augmenting RadioTherapy in REctal Cancer to Minimise Invasive Surgery (ARTEMIS)

ARTEMIS is a phase II,multi-centre,open-label,randomised controlled trial using IMRT/VMAT/TomoTherapy,comparing radiotherapy (SCRT/LCCRT) followed by chemotherapy (FOLFOX/CAPOX),with or without the addition of AN0025 throughout treatment. Eligible patients will have moderate to high-risk rectal cancer where pre-operative chemoradiotherapy (CRT) or total neoadjuvant treatment (TNT) are standard treatment options and who are interested in organ preservation. ARTEMIS uses the Sargent’s three-outcome two-stage comparative design,including an interim analysis for futility. The trial will randomise 140 patients,from 15-20 UK radiotherapy sites,with a 1:1 allocation ratio to receive ...

GO TO STUDY Go

Oral and Gastrointestinal

Randomised controlled trial of EArly transjugular intrahepatiC porTosystemic stent-shunt in Acute Variceal Bleeding (REACT-AVB)

Cirrhosis (scarring of the liver) can lead to varices (abnormally enlarged veins) developing in the lower gullet (food pipe) or stomach causing the varices to bleed. Variceal bleeding is a serious complication of liver cirrhosis. The currently accepted treatment for patients who bleed from varices is known as standard of care (SOC) and includes using an endoscope (a bendy tube incorporating light and a tiny video camera) to tie off an enlarged vein with a rubber ring (variceal banding) or ...

GO TO STUDY Go

Cancer and neoplasms

Relapsed Follicular lymphoma Randomised trial Against standard ChemoTherapy (REFRACT): A randomised phase II trial of investigator choice standard therapy versus sequential novel therapy experimental arms

A prospective,randomised,phase II platform trial for sequential evaluation of experimental treatments versus investigator choice standard therapy (ICT) for patients with relapsed or refractory follicular lymphoma (rrFL). There are three sequential treatment rounds; each has a control arm of ICT and an experimental novel treatment arm. Patients in Round 1 (R1) will be randomised using a 1:1 allocation ratio to receive either ICT or epcoritamab + lenalidomide (experimental treatment). Patients in Rounds 2 (R2) and 3 (R3) (experimental treatments yet to ...

GO TO STUDY Go

Musculoskeletal

A single-centre, randomised, parallel group, double-blinded placebo-controlled study to compare the impact of noninvasive pre-operative electrical stimulation versus placebo on nerve regeneration following decompression surgery for carpal tunnel syndrome (PROSpeCT)

PROSpeCT is about improving recovery after surgery for carpal tunnel syndrome. Carpal tunnel syndrome is a hand disease, involving compression of the median nerve at the wrist. The median nerve controls the muscles of the thumb and feeling in much of the hand. Compression of the nerve leads to pain, tingling and weakness. Most people with CTS eventually need wrist surgery to decompress the nerve. However, as many as one in four people still get symptoms after their surgery. We ...

GO TO STUDY Go